Rocket Pharmaceuticals, Inc. ( RCKT) - Key Metrics
RCKT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | $1.09 | -$0.35 | -$0.35 |
| 2026Q1 | $0 | -$0.42 | -$0.40 | -$0.41 |
| 2025Q4 | $0 | -$0.38 | -$0.31 | -$0.31 |
| 2025Q3 | $0 | -$0.45 | -$0.45 | -$0.45 |
| 2025Q2 | $0 | -$0.62 | -$0.44 | -$0.44 |
RCKT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 0.78 |
| 2026Q1 | 0% | -2.13 |
| 2025Q4 | 0% | -2.31 |
| 2025Q3 | 0% | -1.81 |
| 2025Q2 | 0% | -0.99 |
RCKT
Price: $2.62
52 week price:
Earnings Per Share: -0.17 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 607900
Market Capitalization: 421.5 million